CASI Pharmaceuticals Balance Sheet (2021-2026)

Reported Financials

CASI Pharmaceuticals Quarterly Balance Sheet

Periods 17 quarters

Latest Jun 2026

CASI Pharmaceuticals reported total assets of $21.06M and total liabilities of $79.33M for the quarter ended Jun 2026, down 48.4% year over year. This balance sheet covers 17 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	38.70M				47.11M	16.59M	16.92M	19.98M	17.08M	12.20M	9.53M	13.47M	10.90M	6.74M	4.69M	5.63M	3.77M
Short-term InvestmentsInvestments (Current)	9.87M				1.46M	25.11M	19.85M	14.25M	12.01M	6.03M
Cash & Current Investments	48.57M				48.57M	41.70M	36.77M	34.22M	29.09M	18.23M	9.53M	13.47M	10.90M	6.74M	4.69M	5.63M	3.77M
Receivables - NetNet Receivables	9.80M				12.97M	11.11M	12.53M	11.66M	9.55M	5.86M	6.78M	15.35M	7.60M	5.36M	2.61M	4.09M
Receivables - OtherOther Receivables	0.15M	0.04M	0.06M	0.06M	0.06M				0.59M	0.21M	0.96M	0.78M				0.78M
Receivables	9.95M				13.03M	11.11M	12.53M	11.66M	10.14M	6.07M	7.74M	16.12M	7.60M	5.36M	2.61M	4.87M
Raw Materials																0.25M
Work In Process																0.50M
Finished Goods												5.25M				0.84M
Inventory	1.91M				6.14M	8.57M	7.77M	8.83M	15.90M	15.42M	14.61M	5.25M	4.15M	3.40M	2.61M	1.60M	1.84M
Prepaid Assets	1.69M				2.98M	2.63M	1.91M	2.03M	2.56M	2.00M	2.11M	2.89M	2.71M	2.64M	2.01M	2.14M	0.98M
Current Assets	61.97M				73.42M	66.59M	61.00M	58.12M	59.34M	43.15M	37.20M	39.58M	27.16M	18.16M	11.92M	13.46M	10.02M
Non-Current Assets
Construction in Progress	12.10M				5.73M				0.02M
Property, Plant & Equipment (Net)PP&E (Net)	12.71M				11.83M	11.25M	10.12M	9.50M	9.24M	8.79M	8.50M	7.87M	7.66M	7.40M	7.14M	6.97M	6.57M
Long-Term Investments	40.13M				4.40M	4.33M	3.64M	3.61M	1.69M	1.69M	1.77M	1.91M	1.91M	1.72M	1.72M	1.72M	1.72M
Intangibles	12.20M				1.06M	0.81M	0.54M	0.27M	1.84M	1.62M	1.36M	0.24M	0.23M	0.23M	0.22M	0.22M	0.21M
Goodwill & Intangibles	12.20M				1.06M	0.81M	0.54M	0.27M	1.84M	1.62M	1.36M	0.24M	0.23M	0.23M	0.22M	0.22M	0.21M
Other Non-Current Assets	2.18M				1.06M	1.15M	1.21M	1.62M	0.77M	0.70M	0.69M	0.59M	0.59M	0.64M	0.66M	0.74M	0.68M
Non-Current Assets	76.33M				22.81M	21.80M	16.87M	16.11M	15.92M	14.86M	14.08M	14.10M	13.66M	13.04M	12.55M	12.19M	11.04M
Assets	138.30M				96.23M	88.40M	77.87M	74.23M	75.27M	58.01M	51.27M	53.67M	40.82M	31.20M	24.46M	25.65M	21.06M
Liabilities
Current Liabilities
Accounts Payables	10.96M				11.82M	2.83M	2.37M	2.56M	12.29M	0.58M	0.79M	15.34M	1.20M	0.81M	0.56M	24.17M	1.07M
Notes Payables																1.00M	1.47M
Payables	10.96M				11.82M	2.83M	2.37M	2.56M	12.29M	0.58M	0.79M	15.34M	1.20M	0.81M	0.56M	25.17M	2.54M
Accumulated Expenses	10.96M				11.82M	10.53M	9.53M	9.26M		7.96M	8.79M	15.34M	14.03M	18.20M	20.01M	24.17M	25.06M
Other Accumulated Expenses	0.52M				0.65M				1.12M			1.33M	18.49M	18.73M	18.86M	2.23M
Short term Debt												18.39M				19.19M	19.78M
Current Taxes	0.65M				1.90M	0.68M			0.48M
Current Deferred Revenue	2.83M
Total Current Liabilities	13.19M				17.01M	14.04M	11.91M	11.83M	16.73M	8.54M	9.58M	36.45M	33.71M	37.74M	39.42M	49.67M	66.62M
Non-Current Liabilities
Non-Current Debt									18.90M	18.59M	18.47M
Non-Current Deffered Revenue	2.83M
Minority Interest	23.46M				22.36M	22.64M	21.62M	21.64M
Operating Leases	1.11M				0.48M				1.62M			2.54M				1.44M
Other Non-Current Liabilities	14.33M				12.30M	12.14M	12.12M	11.97M	15.48M	15.41M	14.20M	15.37M	15.18M	13.78M	13.63M	13.26M	12.71M
Total Non-Current Liabilities	39.47M				39.36M	36.68M	33.52M	33.47M	35.62M	27.13M	28.05M	36.45M	33.71M	37.74M	39.42M	49.67M	66.62M
Total Liabilities	53.80M				51.66M	48.82M	45.65M	45.43M	51.10M	42.54M	42.25M	51.82M	48.89M	51.51M	53.05M	62.93M	79.33M
Shareholder's Equity
Total Debt									18.90M	18.59M	18.47M	18.39M				20.19M	21.25M
Common Equity	84.50M				44.57M	39.58M	32.23M	28.79M	24.17M	15.47M	9.02M	1.85M	-8.07M	-20.31M	-28.59M	-37.28M	-58.27M
Liabilities and Shareholders Equity	138.30M				96.23M	88.40M	77.87M	74.23M	75.27M	58.01M	51.27M	53.67M	40.82M	31.20M	24.46M	25.65M	21.06M
Treasury Shares	0.01M				0.28M							0.41M				0.41M
Retained Earnings	-605.64M				-637.16M	-642.32M	-651.80M	-655.67M	-660.82M	-670.35M	-677.31M	-700.08M	-710.83M	-724.20M	-735.09M	-748.13M	-768.17M

CASI Pharmaceuticals Balance Sheet API

Pull CASI Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CASIF&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "CASIF", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=CASIF&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

CASI Pharmaceuticals CASIF Balance Sheet (2021-2026)

CASI Pharmaceuticals Quarterly Balance Sheet

CASI Pharmaceuticals Balance Sheet API

Create an account

Sign In

Reset Password